Analyst Ratings for Dolby Laboratories (DLB)
DLB Rating Summary
DLB Price Target Summary
- Highest: $55.00 (Avondale Partners)
- Lowest: $26.00 (JMP Securities)
- Average: $39.44
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$39.44 (+14.5%)
Avg. $ Target:
$39.44 (+14.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/5/2012 | JMP Securities | Downgrade | Market Underperform (Market Perform) |
26.00 (N/A) |
34.10 | 34.43 | 0.97% | Details |
| 7/18/2012 | JPMorgan | Downgrade | Underweight (Neutral) |
43.50 (48.00) |
35.50 | 34.43 | -3.01% | Details |
| 6/28/2012 | Goldman Sachs | New Coverage | Sell (N/A) |
39.00 (N/A) |
41.62 | 34.43 | -17.28% | Details |
| 5/4/2012 | Avondale Partners | Upgrade | Market Outperform (N/A) |
55.00 (N/A) |
45.18 | 34.43 | -23.79% | Details |
| 5/4/2012 | William Blair | Upgrade | Outperform (N/A) |
N/A (N/A) |
45.18 | 34.43 | -23.79% | Details |
| 3/19/2012 | Brigantine Advisors | New Coverage | Buy (N/A) |
43.00 (N/A) |
38.89 | 34.43 | -11.47% | Details |
| 11/22/2011 | Barrington Research | Upgrade | Outperform (N/A) |
N/A (N/A) |
30.50 | 34.43 | 12.89% | Details |
| 11/9/2011 | Piper Jaffray | Downgrade | Neutral (N/A) |
32.00 (N/A) |
31.56 | 34.43 | 9.09% | Details |
| 8/5/2011 | Collins Stewart » Updated 11/14/2011 |
Downgrade | Neutral (N/A) |
35.00 (N/A) |
32.49 | 34.43 | 5.97% | Details |
| 5/6/2011 | Miller Tabak | Downgrade | Neutral (N/A) |
N/A (N/A) |
47.70 | 34.43 | -27.82% | Details |
| 5/6/2011 | Canaccord Genuity » Updated 2/17/2012 |
Downgrade | Hold (N/A) |
42.00 (N/A) |
47.70 | 34.43 | -27.82% | Details |
| 10/14/2010 | Dougherty & Co | New Coverage | Buy (N/A) |
N/A (N/A) |
60.25 | 34.43 | -42.85% | Details |
| 9/22/2010 | Deutsche Bank | Upgrade | Hold (N/A) |
N/A (N/A) |
60.08 | 34.43 | -42.69% | Details |
